CVE-2025-62287 is a vulnerability identified in Oracle Life Sciences InForm version 7.0.1.0, specifically within its web server component. The flaw allows an unauthenticated attacker with network access over HTTP to compromise the system by exploiting a weakness that requires user interaction from a third party (not the attacker). This interaction could involve social engineering or tricking a legitimate user into performing an action that facilitates the attack. The vulnerability leads to unauthorized capabilities including update, insert, or delete operations on some accessible data, as well as unauthorized read access to a subset of data within Oracle Life Sciences InForm. The scope of impact extends beyond the InForm product itself, potentially affecting other integrated Oracle Health Sciences applications. The CVSS 3.1 vector (AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N) indicates the attack can be launched remotely over the network with low complexity and no privileges, but requires user interaction, and results in a scope change where the attacker’s control extends beyond the initially vulnerable component. The confidentiality and integrity of data are impacted, but availability remains unaffected. No patches or known exploits are currently documented, emphasizing the need for proactive mitigation.

For European organizations, particularly those in pharmaceutical research, clinical trials, and healthcare sectors that rely on Oracle Life Sciences InForm, this vulnerability poses a significant risk to sensitive clinical data integrity and confidentiality. Unauthorized data modification could compromise clinical trial results, regulatory compliance, and patient safety data, leading to reputational damage and potential legal consequences under GDPR. The scope change implies that other integrated Oracle products could also be affected, amplifying the risk. Since the attack requires user interaction, phishing or social engineering campaigns targeting employees could be a likely exploitation vector. The medium severity rating reflects a moderate but tangible threat that could disrupt critical scientific workflows and data trustworthiness in European healthcare and life sciences organizations.

Organizations should immediately verify if they are running Oracle Life Sciences InForm version 7.0.1.0 and prioritize patching once Oracle releases an official fix. In the interim, restrict HTTP network access to the InForm web server to trusted internal networks only, employing network segmentation and firewall rules to limit exposure. Implement robust user awareness training to reduce the risk of social engineering attacks that could facilitate the required user interaction. Employ multi-factor authentication and monitor user activity logs for unusual access patterns or data modifications. Additionally, conduct thorough audits of data integrity and access controls across Oracle Health Sciences applications to detect any unauthorized changes. Consider deploying web application firewalls (WAFs) with custom rules to detect and block suspicious HTTP requests targeting InForm. Finally, maintain up-to-date incident response plans tailored to healthcare and clinical data breaches.